Information Provided By: 
Fly News Breaks for June 30, 2015
JUNO, CELG
Jun 30, 2015 | 07:47 EDT
After Celgene (CELG) announced that it would collaborate with Juno Therapeutics (JUNO) for access to CAR- T therapies, Bernstein says that the $1B that Celgene paid was a high price. The firm thinks that CAR T is unproven beyond CD19 and faces many hurdles. However, it keeps an Outperform rating on Celgene.
News For CELG;JUNO From the Last 2 Days
There are no results for your query CELG;JUNO
